// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Patient Reported Outcomes Following Renal Transplantation: The Future of Holistic Post-Transplant Care

H. V. Spiers - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Phase I/ii Car-Treg Cell Therapy Clinical Trial To Induce Long-term Tolerance In Liver Transplant Patients

A. Sanchez-Fueyo - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pre-Transplant Ex-Vivo Analysis of Kidney Vasculature and Perfusion Using Contrast Computed Tomography

A. Feizi - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Ischemia-reperfusion injury

N/A

Predictors Associated with Survival Outcomes for DCD and DBD Renal Transplants from D4 Donors. A Registry Based Machine Learning Analysis (MLA)

H. Sharma - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Rhabdomyosarcoma

N/A

Predictors of Short and Long Term Outcomes of Donor After Cardiac Death (DCD) versus Donor After Brain Death (DBD) Kidney Transplantation from Supra Marginal Donors ( D4). A Machine Learning Analysis (MLA) of NHSBT Registry Data Since Year 2000

H. Sharma - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Rhabdomyosarcoma

N/A

Reduced CD45RA-CCR7- Tregs Subtypes in Highly Sensitised Patients Associates with a Failure to Regulate Memory IFNγ Production in Response to Donor Alloantigens

C. Dudreuilh - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interferon Gamma

Regulation of Cell Death During Cold Preservation of Marginal Human Kidneys

J. R. DiRito - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Coronary Artery Disease

N/A

Regulatory T Cells Suppress Memory IFN-Gamma Production in Highly Sensitised Patients

C. Dudreuilh - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interleukin

Regulatory T Cells Suppress Memory IL-17a Production in Highly Sensitised Patients with End-Stage Renal Disease

C. Dudreuilh - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Microvascular complications of diabetes 1

Interleukin

Sarcopenia and Obesity in Renal Transplant Recipients – Effects on Graft and Patient Outcomes

C. Seet - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Sarcopenia

N/A

Single Dose Alemtuzemab Provides Comparable Rejection Free and Infection Free Survival Compared to Double Dose Alemtuzumab. In Comparison to Alemtuzemab, Basiliximab Has Superior Infection Free Graft Survival. Results from a Steroid Sparing Transplant Group

H. Sharma - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alemtuzumab

Tacrolimus After Rabbit Antithymocyte Globulin And Infliximab Induction Immunosuppression In Kidney Transplantation

O. Viklicky - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Transplant rejection

Thymoglobuline

The Effect of COVID-19 Pandemic in Intestinal Rehabilitation and Transplant Patients – International Multicenter Survey

M. Segovia - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The Post-operative Clinical Outcomes Of 59 Tanrp Cases In An International Cohort

J. Louca - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Transplant Patients Risk for SARS-CoV-2 Infection Post-2nd Vaccine Dose; We Are Not Home and Dry Yet

G. Koimtzis - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Use of Organ-Specific Chimeric Antigen Receptor Promotes Liver Recruitment of Regulatory T Cells

E. Landmann - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Utilisation and Clinical Outcomes of Kidney Transplants from Deceased Donors with Albuminuria in the UK: A Cohort Study

G. Greenhall - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Albuminuria

N/A

Mitral valve abnormalities in decedents of sudden cardiac death due to hypertrophic cardiomyopathy and idiopathic left ventricular hypertrophy

Raghav Bhatia - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular hypertrophy

N/A

Prevalence and diagnostic significance of novel 12 lead ecg patterns following COVID 19 infection in elite soccer players

Raghav Bhatia - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Progressive cardiac conduction defect

N/A

Clinical outcomes and myocardial recovery in energetics perfusion and contractile function after vavle replacement surgery in severe aortic stenosis patients with diabetes comorbidity

Nicholas Jex - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Adenosine

Copyright © 2026. QuantiNova All rights reserved